Indications for and Experience With the Wearable Cardioverter Defibrillator (WCD) - Austrian WCD Registry
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Heart Failure
- Sponsor
- Medical University of Graz
- Enrollment
- 450
- Locations
- 1
- Primary Endpoint
- Number of participants treated with WCD-treated ventricular arrhythmias
- Last Updated
- 4 years ago
Overview
Brief Summary
Background: The wearable cardioverter defibrillator (WCD) is an established treatment option for patients at high risk for ventricular tachycardia / ventricular fibrillation (VT/VF), either in whom this risk may only be temporarily present, or in patients at high risk for sudden cardiac death (SCD) or after VT/VF in whom an implantable cardioverter defibrillator (ICD is currently not possible for other reasons (infection, recent MI <40days, recent PCI/CABG < 3months etc.).
Methods: Comprehensive registry including all patients in Austria who received a WCD in 2010-2016.
Detailed Description
Observational study to describe WCD indications, event rates, inappropriate shock rates and follow up (including ICD rate, shock rate, morbidity and mortality) in all Austrian WCD patients
Investigators
Scherr Daniel, MD
Austrian Wearable Cardioverter Defibrillator Registry
Medical University of Graz
Eligibility Criteria
Inclusion Criteria
- •patients, with a prescribed WCD according to guidelines in an austrian center
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Number of participants treated with WCD-treated ventricular arrhythmias
Time Frame: during WCD wearing period; average of 1 year
Number of participants treated with WCD-treated ventricular arrhythmias